Jane Street’s Kestra Medical Technologies KMTS Stock Holding History

Jane Street’s Portfolio KMTS Stock Details KMTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,697	Closed	-$257K	–	13415
2025 Q4	$257K	Sell	9,697 -907	-9%	-$23.4K	﹤0.01%	9181
2025 Q3	$252K	Buy	+10,604	New	+$190K	﹤0.01%	9249
2025 Q2	–	Sell	-30,350	Closed	-$756K	–	11331
2025 Q1	$756K	Buy	+30,350	New	+$697K	﹤0.01%	6086

Other funds holding KMTS

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Andera Partners Paris $177M AUM

Yu Fan $97M AUM 57.2% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jane Street's KMTS Position: Q1 2026 in Review

Jane Street sold out of Kestra Medical Technologies (KMTS) in Q1 2026, closing a stake of 9,697 shares — an estimated $257K sold.

Jane Street first reported a position in KMTS in Q1 2025 and held it in 3 quarters. The position peaked at $756K in Q1 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

Jane Street reported no remaining Kestra Medical Technologies position as of Q1 2026 after selling out during the quarter.
Jane Street sold 9,697 Kestra Medical Technologies shares in Q1 2026, an estimated $257K.
Jane Street first reported a position in Kestra Medical Technologies in Q1 2025 and held it in 3 quarters.
Jane Street's Kestra Medical Technologies position peaked at $756K in Q1 2025.
103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.